FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal stromal cells (MSC), ...
Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization ...
INmune Bio Inc. (NASDAQ: INMB) (“INmune Bio”), a clinical-stage biotechnology company, and Anthony Nolan, a pioneering UK-based charity that set up the world's first stem cell register and is now ...
MSC programs often fail at scale due to early design choices. Dr. John Shyu explains how culture systems, media, and process ...
The promise of mesenchymal stem cells (MSCs) to heal heart disease could be around the corner thanks to a new delivery method tested by regenerative medicine company Cynata Therapeutics Ltd.
Figure 1: Immunomodulatory effects of simulated MSCs. MSCs utilize different molecular mechanisms to suppress (in most cases) or activate immune cells. Orange arrows: inhibition; Green arrows: ...
BioWorld - Tuesday, May 20, 2025 See today's BioWorld MedTech See today's BioWorld Home » Cynata’s MSC cells show positive results across variety of delivery systems To read the full story, subscribe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results